BEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY has a total of 29 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, Israel and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are CELLGATE INC, HORMOS MEDICAL CORP and SILANES SA DE CV LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Israel | 7 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 2 | |
#5 | Japan | 2 | |
#6 | China | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Biotechnology | |
#5 | Measurement | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Priel Esther | 8 |
#2 | Yitzchak Sara | 5 |
#3 | Rapaport Hanna | 4 |
#4 | Gazit Aviv | 4 |
#5 | Slavin Shimon | 4 |
#6 | Aviv Gazit | 3 |
#7 | Shimon Slavin | 3 |
#8 | Esther Priel | 3 |
#9 | Lichtenstein Rachel | 2 |
#10 | Cohen Smadar | 2 |
Publication | Filing date | Title |
---|---|---|
IL231074D0 | Method for attribute based broadcast encryption with permanent revocation | |
US2014155511A1 | Sulfur chelated ruthenium compounds useful as olefin metathesis catalysts | |
US2015051148A1 | Hydrogel system comprising spatially separated bioactive polypeptides | |
WO2013084236A1 | Diagnostic and therapeutic methods and their application in amyotrophic lateral sclerosis (als) | |
IL222389D0 | Sulfotransferase of a red microalga and uses thereof | |
IL220743D0 | Desaturases of a green microalga and uses thereof | |
EP2394323A1 | Systems and methods for bio-electricity production |